Cizzle Biotechnology Holdings Plc (LON:CIZ)

London flag London · Delayed Price · Currency is GBP · Price in GBX
2.350
+0.100 (4.44%)
Mar 26, 2026, 9:54 AM GMT
Market Cap8.92M +50.0%
Revenue (ttm)n/a
Net Income-1.12M
EPS-0.00
Shares Out396.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume662,580
Average Volume1,895,869
Open2.166
Previous Close2.250
Day's Range2.000 - 2.500
52-Week Range1.200 - 2.990
Beta0.51
RSI63.91
Earnings DateApr 30, 2026

About LON:CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Employees 4
Stock Exchange London Stock Exchange
Ticker Symbol CIZ
Full Company Profile

Financial Performance

Financial Statements